Key result
Human anti-mouse antibody interference causes false-positive BNP in a low-risk PE patient.
Why the study?
Commercial B-type natriuretic peptide immunoassays can be subject to interference from various factors, leading to potentially misleading results.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Clinicians should consider assay interference from human anti-mouse antibodies when BNP results are surprisingly high and inconsistent with the clinical presentation.
B-type natriuretic peptide, which was initially isolated from porcine brain tissue, has been used in the clinic as an important indicator for the diagnosis, risk stratification, and prognosis of heart failure. In recent years, many commercial immunoassays to assess B-type natriuretic peptide have been reported to undergo interference due to various factors. At present, the commonly used assays to assess B-type natriuretic peptide are enzyme-linked immunosorbent assay and direct chemiluminescence, which are based on a "sandwich structure" formed by dual antibodies; both assays have been reported to undergo interference. We report the case of a patient whose B-type natriuretic peptide results, which were detected using a cyclic amplified fluorescence immunoassay, were false-positive. The patient had a low-risk pulmonary embolism without right heart failure; however, her B-type natriuretic peptide results were surprisingly high. Further study confirmed that the abnormal B-type natriuretic peptide result was caused by the interference of the human anti-mouse antibodies. Therefore, when encountering B-type natriuretic peptide results that are not consistent with the clinical situation, the possibility of interference in the assay should be considered.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2025) conducted a case report in False-positive B-type natriuretic peptide (n=1). Cyclic amplified fluorescence immunoassay for B-type natriuretic peptide was evaluated on False-positive B-type natriuretic peptide result. A cyclic amplified fluorescence immunoassay produced a false-positive B-type natriuretic peptide result in a patient with low-risk pulmonary embolism due to human anti-mouse antibody interference.
Synapse has enriched 10 related papers. Consider them for comparative context: